Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Denver. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Denver at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This is a multicenter, randomized, open-label, Phase 3 study in participants with newly diagnosed multiple myeloma to evaluate the benefits of teclistamab in combination with lenalidomide and teclistamab alone versus lenalidomide alone as maintenance therapy after autologous stem cell transplant.
Sponsor: Stichting European Myeloma Network
Check if you qualify for this multiple myeloma clinical trial in Denver, CO
If you're searching for multiple myeloma treatment options in Denver, CO, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Denver research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.